Colorectal cancer (CRC) screening reduces mortality, but variation exists in uptake. Ethnicity is suggested to play a role; however, there is no high-level evidence to support this. We aim to clarify the impact of Ethnicity on CRC screening uptake and our barriers to its understanding.
Methods:
A systematic review to identify studies reporting on the participation of ethnic minorities in CRC screening worldwide was performed. MEDLINE, Embase, Scopus and Google Scholar databases up until 31 May 2019 were searched. Compliance with screening according to ethnic groups and screening modality was evaluated compared to the ‘White’ control group.
Results:
Twenty-two studies were included in the review reporting on 2,084,213 patients. Substantial variation in categorisation of ethnicities (40 sub-categories), screening modality studied and confounding factors accounted for was observed. 8/15 studies for ‘Blacks’, 10/13 for ‘Hispanics’, 2/2 for ‘Asians’ and 1/1 for ‘South East Asians’ suggest a less likely or significantly decreased compliance with screening for all screening modalities (p < .05) compared to ‘Whites’. Interestingly ‘Japanese’, ‘Vietnamese’ and ‘Filipino’ groups consistently show no difference in the uptake of CRC screening compared to the ‘White’ majority.
Conclusion:
This is the only systematic review on this topic. It highlights the inconsistency in screening uptake behaviour in different ethnic minority groups and identifies barriers like variation in ethnicity categorisation, screening modality and study design utilised to understanding the intricacies of this relationship. Further collaboration and action needs to be undertaken internationally to clarify and improve inequity in the uptake of screening.
PignoneMRichMTeutschSMet al. Screening for colorectal cancer in adults at average risk: a summary of the evidence for the US Preventive Services Task Force. Ann Intern Med2002;137(2):132–41.
3.
HewitsonPGlasziouPWatsonEet al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol2008;103(6):1541–9.
4.
SteeleRJStannersGLangJet al. Interval cancers in a national colorectal cancer screening programme. United European Gastroenterol J2016;4(4):587–94.
5.
MandelJSChurchTRBondJHet al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med2000;343(22):1603–7.
6.
SchreudersEHRucoARabeneckLet al. Colorectal cancer screening: a global overview of existing programmes. Gut2015;64(10):1637–49.
Bibbins-DomingoKGrossmanDCCurrySJet al. Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA2016;315(23):2564–75.
9.
GuptaSSussmanDADoubeniCAet al. Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst2014;106(4):dju032.
10.
RobbinsASSiegelRLJemalA. Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol2012;30(4):401–5.
11.
SonejiSIyerSSArmstrongKet al. Racial disparities in stage-specific colorectal cancer mortality: 1960–2005. Am J Public Health2010;100(10):1912–6.
12.
MoherDLiberatiATetzlaffJet al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg2010;8(5):336–41.
AtaAElzeyJDInsafTZet al. Colorectal cancer prevention: adherence patterns and correlates of tests done for screening purposes within United States populations. Cancer Detect Prev2006;30(2):134–43.
15.
BurgessDJvan RynMGrillJet al. Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines. J Gen Intern Med2011;26(3):251–8.
16.
CaloWAVernonSWLairsonDRet al. Associations between contextual factors and colorectal cancer screening in a racially and ethnically diverse population in Texas. Cancer Epidemiol2015;39(6):798–804.
17.
CrawfordNDJonesCPRichardsonLC. Understanding racial and ethnic disparities in colorectal cancer screening: Behavioral Risk Factor Surveillance System, 2002 and 2004. Ethn Dis2010;20(4):359–65.
18.
De JesusMPuleoESheltonRCet al. Factors associated with colorectal cancer screening among a low-income, multiethnic, highly insured population: does provider’s understanding of the patient’s social context matter?J Urban Health2010;87(2):236–43.
19.
DoubeniCALaiyemoAOReedGet al. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev2009;18(8):2170–5.
20.
DoubeniCALaiyemoAOKlabundeCNet al. Racial and ethnic trends of colorectal cancer screening among Medicare enrollees. Am J Prev Med2010;38(2):184–91.
21.
IoannouGNChapkoMKDominitzJA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol2003;98(9):2082–91.
22.
MehtaSJJensenCDQuinnVPet al. Race/ethnicity and adoption of a population health management approach to colorectal cancer screening in a community-based healthcare system. J Gen Intern Med2016;31(11):1323–30.
23.
RamaiDEtienneDAyideGet al. Individual and geospatial characteristics associated with use and nonuse of the fecal immunochemical test (FIT) for colorectal cancer screening in an urban minority population. J Clin Gastroenterol2019;53(10):744–9.
24.
WalshJMKaplanCPNguyenBet al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med2004;19(2):156–66.
25.
WeeCCMcCarthyEPPhillipsRS. Factors associated with colon cancer screening: the role of patient factors and physician counseling. Prev Med2005;41(1):23–9.
26.
WhiteAVernonSWFranziniLet al. Racial and ethnic disparities in colorectal cancer screening persisted despite expansion of Medicare’s screening reimbursement. Cancer Epidemiol Biomarkers Prev2011;20(5):811–7.
27.
HomayoonBShahidiNCCheungWY. Impact of Asian ethnicity on colorectal cancer screening: a population-based analysis. Am J Clin Oncol2013;36(2):167–73.
28.
LissDTBakerDW. Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care. Am J Prev Med2014;46(3):228–36.
29.
RobbKAPowerEAtkinWet al. Ethnic differences in participation in flexible sigmoidoscopy screening in the UK. J Med Screen2008;15(3):130–6.
30.
WongSTGildengorinGNguyenTet al. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites. Cancer2005;104(Suppl. 12):2940–7.
31.
SzczepuraAPriceCGumberA. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health2008;8(1):346.
32.
DomingoJBChenJJBraunKL. Colorectal cancer screening compliance among Asian and Pacific Islander Americans. J Immigr Minor Health2018;20(3):584–93.
33.
DeutekomMvan RijnAFDekkerEet al. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands. Eur J Public Health2009;19(4):400–2.
34.
KimJWangHYoungLet al. An examination of multilevel factors influencing colorectal cancer screening in primary care accountable care organization settings: a mixed-methods study. J Public Health Manag Pract2019;25(6):562–70.
35.
RastogiNXiaYInadomiJMet al. Disparities in colorectal cancer screening in New York City: an analysis of the 2014 NYC Community Health Survey. Cancer Med2019;8(5):2572–9.
36.
VernonSW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst1997;89(19):1406–22.
37.
HumesKHoganH. Measurement of race and ethnicity in a changing, multicultural America. Race Soc Probl2009;1:111.
38.
Burnett-HartmanANMehtaSJZhengYet al. Racial/ethnic disparities in colorectal cancer screening across healthcare systems. Am J Prev Med2016;51(4):e107–15.
39.
RahmanRSchmaltzCJacksonCSet al. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med2015;4(12):1863–70.
40.
Honein-AbouHaidarGNKastnerMVuongVet al. Systematic review and meta-study synthesis of qualitative studies evaluating facilitators and barriers to participation in colorectal cancer screening. Cancer Epidemiol Biomarkers Prev2016;25(6):907–17.
41.
PampelFCKruegerPMDennyJT. Socioeconomic disparities in health behaviours. Annu Rev Sociol2010;36:349–70.
42.
Unanue-ArzaSSolís-IbinagagoitiaMDíaz-SeoaneMet al. Inequalities and risk factors related to non-participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health2021;31(2):346–55.
43.
HirstYStoffelSBaioGet al. Uptake of the English Bowel (Colorectal) Cancer Screening Programme: an update 5 years after the full roll-out. Eur J Cancer2018;103:267–73.
44.
Afable-MunsuzALiangSYPonceNAet al. Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med2009;24(8):963–70.
45.
YipMPTuSPChunAet al. Participation in colorectal cancer screening among Chinese Americans. Asian Pac J Cancer Prev2006;7(4):645–50.
46.
HondaK. Factors associated with colorectal cancer screening among the US urban Japanese population. Am J Public Health2004;94(5):815–22.
47.
MaxwellAEBastaniRWardaUS. Demographic predictors of cancer screening among Filipino and Korean immigrants in the United States. Am J Prev Med2000;18(1):62–8.
48.
Sekhon Inderjit SinghHKLalNMajeedAet al. Ethnic disparities in the uptake of colorectal cancer screening: an analysis of the West London population. Colorectal Dis2021;23(7):1804–13.
HirstYSkrobanskiHKerrisonRSet al. Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial. Br J Cancer2017;116(11):1408–14.
51.
WardleJvon WagnerCKralj-HansIet al. Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials. Lancet2016;387(10020):751–9.
52.
CramPFendrickAMInadomiJet al. The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. Arch Intern Med2003;163(13):1601–5.
53.
KussmanMJ. Colorectal cancer screening (VHA Directive 2007-004). Washington, DC: Department of Veterans Affairs, Veterans Health Administration, 2007.
54.
LevinTR. Editorial: it’s time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol2009;104(4):939–41.
55.
AustinKLPowerESolarinIet al. Perceived barriers to flexible sigmoidoscopy screening for colorectal cancer among UK ethnic minority groups: a qualitative study. J Med Screen2009;16(4):174–9.
56.
KooJHLeongRWChingJet al. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study. Gastrointest Endosc2012;76(1):126–35.
57.
Aubin-AugerIMercierALebeauJPet al. Obstacles to colorectal screening in general practice: a qualitative study of GPs and patients. Fam Pract2011;28(6):670–6.
58.
BeekerCKraftJMSouthwellBGet al. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health2000;25(3):263–78.
59.
HoffGDominitzJA. Contrasting US and European approaches to colorectal cancer screening: which is best?Gut2010;59(3):407–14.
60.
DoughertyMKBrennerATCrockettSDet al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med2018;178(12):1645–58.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
